Always refer to the individual SmPC for specific guidance
These decreases become clinically significant when sildenafil is combined with other vasodilators
Then came ACHIEVE-3 , published in The Lancet in February 2026, the first direct head-to-head comparison between two oral GLP-1 therapies
According to a company statement, there have been hundreds of reports submitted to the FDAs voluntary adverse event reporting system related to compounded semaglutide
DAB, USP, or EP compliance references on a COA indicate that the test methods used conform to the specifications of a recognized pharmacopeia (Deutsche Arzneimittelbuch, United States Pharmacopeia, European Pharmacopeia)
The announcement immediately landed in the middle of the broader compounded GLP-1 conversation, namely, whether these offerings fit within narrow, patient-specific compounding exceptions permitted under the Federal Food, Drug, and Cosmetic Act (FDCA), or whether they were being positioned as scaled substitutes for FDA-approved products, which is where FDA scrutiny and branded manufacturer enforcement tend to converge